ATE514081T1 - T-zellen-testverfahren - Google Patents

T-zellen-testverfahren

Info

Publication number
ATE514081T1
ATE514081T1 AT07712817T AT07712817T ATE514081T1 AT E514081 T1 ATE514081 T1 AT E514081T1 AT 07712817 T AT07712817 T AT 07712817T AT 07712817 T AT07712817 T AT 07712817T AT E514081 T1 ATE514081 T1 AT E514081T1
Authority
AT
Austria
Prior art keywords
cell responses
testing procedure
cell testing
cell
novel
Prior art date
Application number
AT07712817T
Other languages
English (en)
Inventor
Mathew Baker
Francis Carr
Alyson Rust
Laura Davies
Original Assignee
Antitope Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0604170A external-priority patent/GB0604170D0/en
Priority claimed from GB0619374A external-priority patent/GB0619374D0/en
Priority claimed from GB0620123A external-priority patent/GB0620123D0/en
Application filed by Antitope Ltd filed Critical Antitope Ltd
Application granted granted Critical
Publication of ATE514081T1 publication Critical patent/ATE514081T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
AT07712817T 2006-03-02 2007-03-02 T-zellen-testverfahren ATE514081T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0604170A GB0604170D0 (en) 2006-03-02 2006-03-02 T cell assays
GB0619374A GB0619374D0 (en) 2006-09-29 2006-09-29 T cell asays
GB0620123A GB0620123D0 (en) 2006-10-11 2006-10-11 T cell assays
PCT/GB2007/000736 WO2007099341A1 (en) 2006-03-02 2007-03-02 T cell assays

Publications (1)

Publication Number Publication Date
ATE514081T1 true ATE514081T1 (de) 2011-07-15

Family

ID=38191208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07712817T ATE514081T1 (de) 2006-03-02 2007-03-02 T-zellen-testverfahren

Country Status (13)

Country Link
US (1) US20090221024A1 (de)
EP (1) EP1989544B1 (de)
JP (1) JP5161798B2 (de)
KR (1) KR101361887B1 (de)
AT (1) ATE514081T1 (de)
AU (1) AU2007220300A1 (de)
CA (1) CA2644540C (de)
DK (1) DK1989544T3 (de)
PL (1) PL1989544T3 (de)
PT (1) PT1989544E (de)
RU (1) RU2476884C2 (de)
SG (1) SG170051A1 (de)
WO (1) WO2007099341A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20090514A1 (en) 2009-07-06 2011-02-16 Opsona Therapeutics Ltd Humanised antibodies and uses therof
CA2772076A1 (en) 2009-08-24 2011-03-10 Baylor College Of Medicine Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
WO2011027810A1 (ja) * 2009-09-03 2011-03-10 独立行政法人理化学研究所 アレルゲン特異的リンパ球の検出方法
EP3366308A1 (de) 2009-09-06 2018-08-29 Protab Ltd. Für das aus hsp65 gewonnene peptid 6 spezifische humanisierte antikörper und verwendungen davon
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
EP2812431B1 (de) 2012-02-09 2019-07-17 Baylor College Of Medicine Peptidmischungen zur erzeugung multiviraler ctl mit breiter spezifität
RU2681994C2 (ru) 2012-12-26 2019-03-14 Онкосинерджи, Инк. КОМПОЗИЦИИ АНТИТЕЛА К ИНТЕГРИНУ β1 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
WO2014180490A1 (en) * 2013-05-10 2014-11-13 Biontech Ag Predicting immunogenicity of t cell epitopes
US11167024B2 (en) 2015-09-18 2021-11-09 Baylor College Of Medicine Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
EP3564386B1 (de) * 2016-12-27 2021-12-08 Chugai Seiyaku Kabushiki Kaisha Verfahren zur auswertung der immunogenität einer testsubstanz
RU2722648C2 (ru) * 2018-11-16 2020-06-02 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Способ проверки иммуногенности вакцинных антигенов для получения высокоэффективных вакцин против опасных инфекций

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039721A2 (en) * 1996-04-23 1997-10-30 President And Fellows Of Harvard College Methods and compositions for regulating t cell subsets by modulating transcription factor activity
EP1021537A1 (de) * 1997-10-10 2000-07-26 Basf Ag Moleküle, die mit dem t-zell rezeptor asssoziiert sind (trams), und verfahren zueren verwendung
CA2326389C (en) * 1998-04-21 2007-01-23 Micromet Gesellschaft Fur Biomedizinische Forschung Mbh Novel cd19xcd3 specific polypeptides and uses thereof
EP1241249A1 (de) * 2001-03-12 2002-09-18 Gerold Schuler Regulatorische CD4+CD25+ T Zellen aus menschlichem Blut
DK1578772T3 (da) * 2002-05-01 2010-08-16 Danisco Us Inc Cytokiner og cytokinreceptorer med reduceret immunogenicitet
CA2759572A1 (en) * 2002-08-08 2004-02-19 Baylor College Of Medicine Isolation and identification of t cells
WO2004050706A2 (en) * 2002-12-03 2004-06-17 Medical Research Council Regulatory t-cells

Also Published As

Publication number Publication date
SG170051A1 (en) 2011-04-29
EP1989544B1 (de) 2011-06-22
AU2007220300A1 (en) 2007-09-07
HK1126274A1 (en) 2009-08-28
CA2644540C (en) 2014-09-30
KR101361887B1 (ko) 2014-02-21
US20090221024A1 (en) 2009-09-03
DK1989544T3 (da) 2011-09-26
WO2007099341A1 (en) 2007-09-07
PL1989544T3 (pl) 2012-01-31
RU2476884C2 (ru) 2013-02-27
KR20080109008A (ko) 2008-12-16
PT1989544E (pt) 2011-09-26
RU2008136561A (ru) 2010-04-10
EP1989544A1 (de) 2008-11-12
JP5161798B2 (ja) 2013-03-13
CA2644540A1 (en) 2007-09-07
JP2009528044A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
DK1989544T3 (da) T-celle-testmetode
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
EA200971124A1 (ru) Множественный анализ образцов крови
BR112012021202A2 (pt) aparelho e metodos para preparacao, reacao e deteccao integradas de amostras
BRPI0618713B8 (pt) cardiolipina modificada e seus usos
NO20081374L (no) Analyser og fremgangsmater som benytter biomarkorer
CR20110567A (es) Dispositivos para diagnostico y metodos relacionados
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
NZ609824A (en) Immunochromatography devices, methods and kits
BR112014006432A2 (pt) biomarcadores do câncer de pulmão e seus usos
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
BR112013021666A2 (pt) detecção de capacitância em ensaio eletroquímico com compensação de tempo de amostragem aprimorada
EP3851856A3 (de) Verfahren, array und verwendung davon
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
WO2008073895A3 (en) Methods and devices for testing saliva
BRPI0515223A (pt) dispositivo integrado para análises diagnósticas e método relativo
SG10201908265UA (en) L-fabp immunoassay method and assay reagent used in said method
WO2005075986A3 (en) Method and kit for the measurement of neutrophil cell activation
DE602006018432D1 (de) Antigennachweis
GB201119585D0 (en) Assay
BRPI0513596A (pt) anticorpo enriquecido para detecção de infecção micobacteriana, métodos de uso e teste diagnóstico empregando o mesmo
EP2565647A4 (de) Reagens zum testen eines antikörpers gegen treponema pallidum
RU2009128762A (ru) Способ и набор для иммуноферментного определения функциональной активности компонента с3 комплемента человека
RU2014110231A (ru) Мембранный белок микровезикул и его применение

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1989544

Country of ref document: EP